The ZIPANGU ( Ezetimibe clinical investigation for the regression of intracoronary plaque evaluated by angioscopy and ultrasound ) study is aimed at comparing these two types of therapy based on indices of plaque characteristics using non-obstructive coronary angioscopy and intravascular ultrasound .